drugset / Trial / NCT06042153
DIALYSIS-TIR Study
Phase 4
Active not recruiting
43 enrolled
University of Texas Southwestern Medical Center
University of North Carolina, Chapel Hill · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide to people taking "dummy" medicine. The treatment participants get will be decided randomly. Participants will need to inject the study medication once a week. The study will last for 1 year and a month. Participants will be asked to wear a sensor that measures blood sugar levels for a period of 10 days at five different time points during the study.
Timeline
- Start
- 2023-12-05
- Primary completion
- 2027-09
- Completion
- 2028-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 1 mg | — |